Ultralife Corporation
ULBI
$7.44
$0.223.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.69% | 8.42% | 16.24% | 12.94% | 5.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.69% | 8.42% | 16.24% | 12.94% | 5.86% |
| Cost of Revenue | 4.75% | 11.45% | 18.78% | 16.28% | 8.36% |
| Gross Profit | 4.50% | -0.60% | 8.90% | 3.50% | -1.18% |
| SG&A Expenses | 6.27% | 12.56% | 19.03% | 13.69% | 8.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.27% | 12.24% | 19.19% | 16.57% | 9.08% |
| Operating Income | -23.18% | -48.51% | -23.72% | -31.71% | -30.41% |
| Income Before Tax | -318.61% | -261.16% | -201.17% | -78.91% | -64.21% |
| Income Tax Expenses | -360.12% | -282.57% | -229.33% | -69.99% | -49.40% |
| Earnings from Continuing Operations | -304.02% | -254.18% | -192.85% | -80.78% | -67.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 258.46% | 188.78% | 154.64% | 51.43% | -600.00% |
| Net Income | -304.94% | -255.39% | -193.44% | -80.89% | -68.24% |
| EBIT | -23.18% | -48.51% | -23.72% | -31.71% | -30.41% |
| EBITDA | -12.36% | -28.29% | -8.69% | -15.32% | -17.94% |
| EPS Basic | -304.79% | -254.88% | -192.53% | -81.11% | -68.67% |
| Normalized Basic EPS | -0.38% | -56.26% | -34.97% | -52.82% | -42.90% |
| EPS Diluted | -314.40% | -258.26% | -194.08% | -81.95% | -69.17% |
| Normalized Diluted EPS | -0.17% | -55.87% | -34.35% | -52.49% | -42.59% |
| Average Basic Shares Outstanding | 0.14% | 0.21% | 0.53% | 0.93% | 1.50% |
| Average Diluted Shares Outstanding | -0.45% | -0.79% | -0.51% | 0.07% | 1.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |